Glycogen synthase kinase-3: A promising therapeutic target for Fragile X Syndrome
Recent advances in understanding the pathophysiological mechanisms contributing to Fragile X Syndrome (FXS) have increased optimism that drug interventions can provide significant therapeutic benefits. FXS results from inadequate expression of functional fragile X mental retardation protein (FMRP)....
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2011-11-01
|
| Serie: | Frontiers in Molecular Neuroscience |
| Soggetti: | |
| Accesso online: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2011.00035/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|